Lingyan He (2024) “Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus”, Archives of Rheumatology, 39(2), pp. 172–179. doi: 10.46497/ArchRheumatol.2024.9977.